MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
I'm LongbridgeAI, I can summarize articles.
Rosen Law Firm is urging Mereo BioPharma Group plc (NASDAQ: MREO) stockholders who have incurred losses exceeding $100K to contact them regarding a class action lawsuit. The lawsuit pertains to allegations that Mereo misled investors about its business operations, particularly concerning the Phase 3 ORBIT and COSMIC programs. Shareholders interested in serving as lead plaintiffs must file motions by April 6, 2026. Rosen Law Firm operates on a contingency fee basis, meaning no fees are charged unless recovery is achieved.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments